Skip to main content

Table 3 Clinical and pathological features of the 120 RCT patients included in the study

From: Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel

 

Tumour

Number of patients, n

120

Age, median (range)

60 (29–83)

Gender, n (%)

 Male

73 (61)

 Female

47 (39)

Histological subtype, n (%)

 Clear cell RCC

30 (25)

 Papillary RCC

30 (25)

 Chromophobe RCC

30 (25)

 Oncocytoma

30 (25)

Pathological stage, n (%)

 Stage I

47 (39)

 Stage II

19 (16)

 Stage III

21 (17.5)

 Stage IV

3 (2.5)

 n.a. (oncocytoma)

30 (25)

Nuclear grade, n (%)

 Grade 1

3 (2.5)

 Grade 2

23 (19)

 Grade 3

29 (24.5)

 Grade 4

5 (4)

 n.a. (chRCC and oncocytoma)

60 (50)

Metastasis during follow-up

 Clear cell RCC

9 (7.5)

 Papillary RCC

7 (5.8)

 Chromophobe RCC

1 (0.8)

  1. RCC renal cell carcinoma, chRCC chromophobe renal cell carcinoma, n.a. not applicable